MEDCL · MedinCell SA
24.86
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro944.10M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 08/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 100
- HALO 200
- HALO All
- Recent Earnings downgrade
- Volume Spike
Key Fundamentals
EPS 3 yr Growth
-3.00%
EBITDA Margin
-100.90%
Operating Cashflow
-€31m
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Performance
52 weeks range
Low 19.69 - 39.68
Trade Value (12mth)
US$844,493.00
1 week
9.05%
1 month
19.35%
YTD
6.31%
1 year
-21.55%
All time high
39.68
Additional Data
Shares Outstanding (Fully Diluted)
34m
HALO Sector
Healthcare
Next Company Report Date
15-Jun-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Very Weak
Growth
Earnings
Neutral
Dividends
Very Weak
Quality
Capital Efficiency
Neutral
Balance Sheet
Neutral
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Groupe Industriel Marcel Dassault SAS | Subsidiary |
| Anh Nguyen | Individual |
| BNP Paribas Développement SA | Subsidiary |
| MedinCell SA | Public Company |
